Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
29.35
+0.82 (2.87%)
Apr 8, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Biotechnology
72.30M28.52M7.16M
6.25M79.11M
Biotechnology Growth
153.52%298.16%-
-92.09%395.55%
Total
72.30M28.52M7.16M
6.25M79.11M
Total Growth
153.52%298.16%-
-92.09%395.55%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
72.30M28.52M7.16M
6.25M79.11M
United States Growth
153.52%298.16%-
-92.09%395.55%
Total
72.30M28.52M7.16M
6.25M79.11M
Total Growth
153.52%298.16%-
-92.09%395.55%
Source: S&P Global Market Intelligence.